Ligand-dependent Corepressor (LCoR) Recruitment by Kruppel-like Factor 6 (KLF6) Regulates Expression of the Cyclin-dependent Kinase Inhibitor CDKN1A Gene

被引:37
作者
Calderon, Mario R. [1 ]
Verway, Mark [1 ]
An, Beum-Soo [1 ]
DiFeo, Analisa [3 ,4 ]
Bismar, Tarek A. [5 ]
Ann, David K. [6 ]
Martignetti, John A. [3 ,4 ]
Shalom-Barak, Tali [7 ]
White, John H. [1 ,2 ]
机构
[1] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada
[3] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA
[4] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA
[5] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2V 1P9, Canada
[6] City Hope Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA
[7] Univ Pittsburgh, Dept OBGYN & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15213 USA
基金
加拿大健康研究院;
关键词
PROSTATE-CANCER GROWTH; TUMOR-SUPPRESSOR GENE; UP-REGULATION; E-CADHERIN; TRANSCRIPTIONAL ACTIVATION; RECEPTOR COREPRESSOR; DOWN-REGULATION; REPRESSION; ANDROGEN; PROTEIN;
D O I
10.1074/jbc.M111.311605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The widely expressed transcriptional coregulator, ligand-dependent corepressor (LCoR), initially characterized as a regulator of nuclear receptor-mediated transactivation, functions through recruitment of C-terminal binding proteins (CtBPs) and histone deacetylases (HDACs) to its N-terminal and central domains, respectively. We performed a yeast two-hybrid screen for novel cofactors, and identified an interaction between the C-terminal domain of LCoR and the transcription factor Kruppel-like factor 6 (KLF6), a putative tumor suppressor in prostate cancer. Subsequent experiments revealed LCoR regulation of several KLF6 target genes notably p21(WAF1/CIP1) (CDKN1A) and to a lesser extent E-cadherin (CDH1), indicating that LCoR regulates gene transcription through multiple classes of transcription factors. In multiple cancer cells, LCoR and KLF6 bind together on the promoters of the genes encoding CDKN1A and CDH1. LCoR contributes to KLF6-mediated transcriptional repression in a promoter-and cell type-dependent manner. Its inhibition of reporter constructs driven by the CDKN1A and CDH1 promoters in PC-3 prostate carcinoma cells is sensitive to treatment with the HDAC inhibitor trichostatin A. Additionally, the LCoR cofactor CtBP1 bound the same promoters and augmented the LCoR-dependent repression in PC-3 cells. Consistent with their inferred roles in transcriptional repression, siRNA-mediated knockdown of KLF6, LCoR, or CtBP1 in PC-3 cells induced expression of CDKN1A and CDH1 and additional KLF6 target genes. We propose a novel model of LCoR function in which promoter-bound KLF6 inhibits transcription of the CDKN1A gene and other genes as well by tethering a transcriptional corepressor complex containing LCoR, with specific contributions by CtBP1 and HDACs.
引用
收藏
页码:8662 / 8674
页数:13
相关论文
共 50 条
[1]  
Aaltomaa S, 1999, PROSTATE, V39, P8
[2]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[3]   Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase [J].
Asim, Mohammad ;
Bin Hafeez, Bilal ;
Siddiqui, Imtiaz Ahmad ;
Gerlach, Claudia ;
Patz, Michaela ;
Mukhtar, Hasan ;
Baniahmad, Aria .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (43) :37108-37117
[4]   Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy:: prognostic significance of p21/WAF1/CIP1 expression [J].
Baretton, GB ;
Klenk, U ;
Diebold, J ;
Schmeller, N ;
Löhrs, U .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :546-555
[5]   RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2 [J].
Batsché, E ;
Muchardt, C ;
Behrens, J ;
Hurst, HC ;
Crémisi, C .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :3647-3658
[6]   Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1 [J].
Benzeno, S ;
Narla, G ;
Allina, J ;
Cheng, GZ ;
Reeves, HL ;
Banck, MS ;
Odin, JA ;
Diehl, JA ;
Germain, D ;
Friedman, SL .
CANCER RESEARCH, 2004, 64 (11) :3885-3891
[7]   NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR [J].
CAVAILLES, V ;
DAUVOIS, S ;
LHORSET, F ;
LOPEZ, G ;
HOARE, S ;
KUSHNER, PJ ;
PARKER, MG .
EMBO JOURNAL, 1995, 14 (15) :3741-3751
[8]   Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration [J].
Das, Amitava ;
Fernandez-Zapico, Martin E. ;
Cao, Sheng ;
Yao, Janet ;
Fiorucci, Stefano ;
Hebbel, Robert P. ;
Urrutia, Raul ;
Shah, Vijay H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (51) :39105-39113
[9]   Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia [J].
Devlin, AM ;
Bottiglieri, T ;
Domann, FE ;
Lentz, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25506-25511
[10]   E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor [J].
DiFeo, A. ;
Narla, G. ;
Camacho-Vanegas, O. ;
Nishio, H. ;
Rose, S. L. ;
Buller, R. E. ;
Friedman, S. L. ;
Walsh, M. J. ;
Martignetti, J. A. .
ONCOGENE, 2006, 25 (44) :6026-6031